Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07183046 · ClinicalTrials.gov registry record · NA
Implementation Intention Planning Guide for FIT Colon Cancer Screening
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 1,600
- Enrollment target
NCT07183046: Clinical Trial NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT07183046 is a NA study that has not yet begun recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 1,600 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07183046, a NA study, has not yet begun recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,600 participants
- Enrollment target
Study Summary
Fecal immunochemical tests (FIT) are a primary method of screening for colorectal cancer (CRC). Implementation intention planning involves encouraging completion or eliminating barriers for the participant to make a plan to complete a behavior or activity. This randomized control study seeks to answer whether the addition of an implementation intention guide impacts behaviors when completing FIT screening. The primary objective includes determining if the implementation intention guide increases completion rate of screening FIT. The secondary objectives is whether this intervention decreases the lab sample rejection rate and reduces the duration between sample collection and laboratory receipt/evaluation of screening FIT.
Primary Outcome
Percentage of participants who have completed, returned, and have received completed lab results for FIT 90 days following participant reception of FIT.
Interventions
- BEHAVIORAL Implementation Intention Guide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What is known before NCT07183046 opens enrollment
NCT07183046 is an interventional study that assigns participants to a tested intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher).
The record links to 0 conditions, and to 1 intervention - of which Implementation Intention Guide is the first listed.
NCT07183046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07183046 about?
NCT07183046 is a clinical study titled "Implementation Intention Planning Guide for FIT Colon Cancer Screening". Fecal immunochemical tests (FIT) are a primary method of screening for colorectal cancer (CRC). Implementation intention planning involves encouraging completion or eliminating barriers for the participant to make a plan to complete a behavior or activity. This randomized control study seeks to answ...
What is the current status of trial NCT07183046?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,600 participants. The study started on 2025-10-01. Estimated completion is 2026-06-30.
What interventions are being tested in trial NCT07183046?
The interventions under investigation include: Implementation Intention Guide (BEHAVIORAL).
Who is sponsoring clinical trial NCT07183046?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07183046's enrollment target sits among peer trials
1,600 63rd of 2000 higher than 1,937 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI